iBio, Inc. (NASDAQ:IBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 10, 2026. The Healthcare company reported Q0 revenue of .
iBio, Inc. (NASDAQ:IBIO) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 10, 2026.
The Healthcare company reported Q0 revenue of .
iBio, Inc.'s stock currently trades at $2.27 with a market capitalization of $39.7M.
Current market data
NASDAQ · IBIO
$1.45
Unchanged: $0.00 · 0.00%
Live quote updated
Keep reading
